The Future of Hypoparathyroidism Treatment Market: By 2023 to 2033 Outlook

 

The global hypoparathyroidism treatment market is on the verge of significant expansion, according to a comprehensive market analysis conducted by Future Market Insights. The market, valued at US$ 777.4 million in 2022, is projected to reach an estimated US$ 841.9 million by the close of 2023. Furthermore, the analysis anticipates a steady Compound Annual Growth Rate (CAGR) of 7.7% from 2023 through 2033, culminating in a projected market value of US$ 1,767.4 million at the end of the forecast period.

Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, is identified as a primary catalyst for the escalating demand for innovative treatment modalities. This significant market expansion underscores the growing focus on advancing therapeutic interventions to address the unmet medical needs of individuals affected by this condition.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-7857

"The forecasted growth of the global hypoparathyroidism treatment market reflects the increasing recognition of the challenges faced by patients and healthcare providers in managing this rare disorder," said a spokesperson from Future Market Insights. "As awareness grows and technology continues to evolve, there is a heightened demand for effective and patient-centric treatment options."

The market analysis conducted by Future Market Insights indicates a robust trajectory for the hypoparathyroidism treatment industry, propelled by ongoing efforts to develop effective and patient-centric solutions. The remarkable growth underscores the industry's commitment to addressing the unique challenges posed by hypoparathyroidism and improving the quality of life for those affected.

As the hypoparathyroidism treatment industry continues its upward trajectory, stakeholders, including pharmaceutical companies, healthcare professionals, and researchers, are encouraged to collaborate and innovate in the pursuit of groundbreaking solutions. This growth not only represents a significant market opportunity but also signifies a collective commitment to improving the lives of those grappling with this rare endocrine disorder.

Key Takeaways:

  • Over the next several decades, the Indian market is expected to grow at an 8.6% CAGR.
  • By 2033, the worldwide market is expected to be worth US$ 1767.4 million.
  • The United States has emerged as the dominant market, accounting for more than 37.7% of overall demand in 2022.
  • Over the next several decades, the Chinese market is expected to grow at a CAGR of 7.9%.
  • In 2022, the calcium supplements category accounted for 38.29% of market revenue.

Competitive Landscape:

  • Amolyt Pharma revealed an oral presentation at the 25th European Congress of Endocrinology (ECE) 2023 in May 2023. The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in which numerous individuals have or are at risk of developing osteopenia and osteoporosis.
  • In November 2022, the Food and Drug Administration (FDA) authorized for Priority Assessment a new drug application (NDA) for TransConTM PTH (palopegteriparatide) in adults with hypoparathyroidism.

Key Companies Profiled:

  • Takeda Pharmaceutical Company Limited.
  • Entera Bio Ltd.
  • Amgen Inc.
  • Ascendis Pharma A/S
  • F. Hoffmann-La Roche Ltd
  • ProLynx, Inc.
  • Extend Biosciences, Inc.
  • BionPharma Inc.
  • Teva Pharmaceuticals Ltd.

Hypoparathyroidism Treatment Market Segmentation:

By Product Type:

  • Parathyroid Hormone
    • Natpara
    • Others
  • Vitamin D Analogue
    • Vitamin D2
    • Vitamin D3
  • Calcium Supplements

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more